05.18.2026

SpyGlass Pharma Secures CPT Code for BIM-IOL System

Key Takeaways The AMA approved a new add-on Category III CPT code (+X659T) for the attachment and insertion of SpyGlass Pharma’s investigational BIM-IOL System during routine cataract surgery SpyGlass Pharma’s BIM-IOL System is designed to treat both cataracts and elevated IOP iin a single procedure by delivering bimatoprost continuously for up to 3 years The company is currently conducting two phase 3 registrational trials, with enrollment expected to be completed in 2027  SpyGlass Pharma announced that the American Medical Association’s (AMA) CPT Editorial Panel has approved a new add-on Category III CPT code for the attachment and insertion of an intraocular lens prosthesis-mounted drug-eluting implant. The application was submitted in support of SpyGlass Pharma’s investigational Bimatoprost Drug Pad-IOL System (BIM-IOL System), designed for use alongside standard cataract surgery procedures.